- Home
- MTAL vs AMPH Comparison
MTAL vs AMPH Comparison
Compare MTAL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTAL
- AMPH
- Stock Information
- Founded
- MTAL 2021
- AMPH 1996
- Country
- MTAL Jersey
- AMPH United States
- Employees
- MTAL N/A
- AMPH N/A
- Industry
- MTAL Blank Checks
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- MTAL Finance
- AMPH Health Care
- Exchange
- MTAL Nasdaq
- AMPH Nasdaq
- Market Cap
- MTAL 1.0B
- AMPH 1.1B
- IPO Year
- MTAL 2021
- AMPH 2014
- Fundamental
- Price
- MTAL $12.21
- AMPH $26.98
- Analyst Decision
- MTAL Hold
- AMPH Buy
- Analyst Count
- MTAL 4
- AMPH 6
- Target Price
- MTAL $12.08
- AMPH $35.50
- AVG Volume (30 Days)
- MTAL 1.4M
- AMPH 422.6K
- Earning Date
- MTAL 11-09-2025
- AMPH 11-05-2025
- Dividend Yield
- MTAL N/A
- AMPH N/A
- EPS Growth
- MTAL N/A
- AMPH N/A
- EPS
- MTAL N/A
- AMPH 2.68
- Revenue
- MTAL $321,804,000.00
- AMPH $722,679,000.00
- Revenue This Year
- MTAL $17.39
- AMPH $1.06
- Revenue Next Year
- MTAL $24.69
- AMPH $7.06
- P/E Ratio
- MTAL N/A
- AMPH $10.07
- Revenue Growth
- MTAL N/A
- AMPH 1.37
- 52 Week Low
- MTAL $7.69
- AMPH $20.39
- 52 Week High
- MTAL $14.31
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- MTAL 65.29
- AMPH 41.80
- Support Level
- MTAL $12.12
- AMPH $28.34
- Resistance Level
- MTAL $12.22
- AMPH $29.43
- Average True Range (ATR)
- MTAL 0.03
- AMPH 0.88
- MACD
- MTAL 0.00
- AMPH -0.58
- Stochastic Oscillator
- MTAL 90.00
- AMPH 8.74
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.